Skip to main content
. 2016 Sep 8;16(1):168. doi: 10.1186/s12883-016-0695-z

Table 1.

Baseline demographic characteristics of stroke and non-stroke patients (n = 416)

Variables Stroke n = 358 Non-stroke n = 58 P
Age 69.2 ± 13.8 70.6 ± 11.4 0.397
Male, n (%) 210 (58.7) 37 (63.8) 0.460
SBP, mmHg 168.8 ± 31.9 147.8 ± 27.6 <0.001*
DBP, mmHg 91.8 ± 20.7 80.8 ± 14.3 <0.001*
bpm 80.9 ± 18.1 80.0 ± 13.3 0.742
Medical history, n (%)
 Smoker 146 (40.8) 20 (34.5) 0.339
 Hypertension 202 (56.4) 34 (58.6) 0.992
 Diabetes 58 (16.2) 14 (24.1) 0.157
 Hyperlipidemia 40 (11.2) 9 (15.5) 0.407
 Ischemic heart disease 36 (10.1) 8 (13.8) 0.434
 Atrial fibrillation 28 (7.8) 1 (1.7) 0.148
Symptoms & signs, n (%)
 Asymmetric facial weakness 181 (50.6) 8 (13.8) <0.001*
 Asymmetric arm weakness 217 (60.6) 7 (12.1) <0.001*
 Asymmetric leg weakness 228 (63.7) 9 (15.5) <0.001*
 Speech disturbance 195 (54.5) 17 (29.3) <0.001*
 Visual field defect 68 (19.0) 1 (1.7) 0.001*
 gaze palsy 115 (32.1) 5 (8.6) <0.001*
 Sensory deficits 78 (21.8) 8 (13.8) 0.163
 Loss of consciousness or syncope 119 (33.2) 10 (17.2) 0.015*
 Seizure activity 21 (5.9) 6 (10.3) 0.319
 Pathologic reflex 102 (28.5) 8 (13.8) 0.019*
 Meningeal irritation 22 (6.1) 0 (0) 0.102
 Vertigo 26 (7.3) 19 (32.8) <0.001*
 Headache 25 (7.0) 3 (5.2) 0.816
 Nausea 59 (16.5) 26 (44.8) <0.001*
 Vomiting 51 (14.2) 23 (39.7) <0.001*
Score
 GCS > 8, n (%) 297 (83) 56 (96.6) 0.007*
 GCS ≤ 8, n (%) 61 (17) 2 (3.4) 0.007*
 GCS, median (IQR) 15 (12–15) 15 (15–15) <0.001*

*Statistically significant difference was observed between two groups